Literature DB >> 16142325

Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells.

Maria Viola1, Massimo Libra, Daniela Callari, Fulvia Sinatra, Daniele Spada, Davide Noto, Giovanni Emmanuele, Fabrizio Romano, Maurizio Averna, Franca Maria Pezzino, Franca Stivala, Salvatore Travali.   

Abstract

Bovine seminal-ribonuclease (BS-RNase) is a member of the 'ribonucleases with special biological actions' family since it possesses specific anti-tumour, anti-spermatogenic and embryotoxic activities and exerts an immunosuppressive effect on T lymphocytes. In previous studies it was demonstrated that BS-RNase induced apoptosis in proliferating, malignant and normal cells and that telomerase activity loss also caused apoptotic death in neoplastic cells. Since an obvious relationship between cell proliferation and telomerase activity exists, the aim of this work was to study if the pro-apoptotic cytotoxic action exerted by BS-RNase on proliferating malignant cells (HT29) and proliferating normal cells (PHA-stimulated lymphocytes) could be linked to a possible BS-RNase effect on telomerase activity. In BS-RNase-treated HT29 cells (Na-butyrate-differentiated or not) and human lymphocytes (proliferating or not), we investigated cell vitality (MTT method) and morphology (SEM), BS-RNase localization (immunofluorescence), telomerase activity (TRAP-ELISA method), hTR mRNA expression (RT-PCR), and hTERT levels (western blot). While no BS-RNase effect was detectable on not proliferating cells, a clear relationship was noticed between the diminished number of vital elements of both proliferating cell populations after treatment (48 h and 72 h for HT29 and PHA-stimulated lymphocytes, respectively) with 50 microg/ml BS-RNase and the decrease of their telomerase activity. At the same time, we found that hTR levels, the RNA subunit of telomerase, in proliferation-inhibited BS-RNase-treated cells were diminished. Moreover, by immunofluorescence technique, we detected BS-RNase in the HT29 cell nucleolus after 3-h treatment. Therefore, as hTR has been recently proven to co-fractionate with nucleoli, we hypothesize that a BS-RNase direct action on the telomerase hTR subunit could be a possible mechanism of action by which BS-RNase exerts its pro-apoptotic effects only on proliferating cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142325

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

Review 1.  The RNase a superfamily: generation of diversity and innate host defense.

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

2.  Carboxylated acyclonucleosides: synthesis and RNase A inhibition.

Authors:  Kaustav Chakraborty; Swagata Dasgupta; Tanmaya Pathak
Journal:  Molecules       Date:  2015-04-03       Impact factor: 4.411

3.  Double domain swapping in bovine seminal RNase: formation of distinct N- and C-swapped tetramers and multimers with increasing biological activities.

Authors:  Giovanni Gotte; Alexander Mahmoud Helmy; Carmine Ercole; Roberta Spadaccini; Douglas V Laurents; Massimo Donadelli; Delia Picone
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

4.  Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.

Authors:  Evelina Edelweiss; Taras G Balandin; Julia L Ivanova; Gennady V Lutsenko; Olga G Leonova; Vladimir I Popenko; Alexander M Sapozhnikov; Sergey M Deyev
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.